Davenport & Co LLC
- SEC CIK
- 0000887777
- Latest filing
- Jul 13, 2026
RARE holding history
Ultragenyx Pharmaceutical Inc. in every 13F filed by Davenport & Co LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RARE overviewAll 13F holders of RAREFull Q2 2026 holdings
- Shares (Q2 2026)
- 19,500
- Value
- $651.1K
- % of portfolio
- <0.1%
- Quarters held
- 7
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 19,500 | $651.1K | <0.1% | +2,000+11.4% | Added | Holders |
| Q1 2026 | 17,500 | $366.6K | <0.1% | +17,500 | New | Holders |
| Q3 2022 | 0 | $0 | 0.0% | −5,782−100.0% | Sold out | Holders |
| Q2 2022 | 5,782 | $345.0K | <0.1% | +456+8.6% | Added | Holders |
| Q1 2022 | 5,326 | $387.0K | <0.1% | +1,135+27.1% | Added | Holders |
| Q4 2021 | 4,191 | $352.0K | <0.1% | +56+1.4% | Added | Holders |
| Q3 2021 | 4,135 | $373.0K | <0.1% | +883+27.2% | Added | Holders |
| Q2 2021 | 3,252 | $310.0K | <0.1% | +3,252 | New | Holders |